TipRanks
Advertisement
Advertisement
Race Oncology lodges ASX corporate governance statement for FY26
PremiumCompany AnnouncementsRace Oncology lodges ASX corporate governance statement for FY26
28d ago
Racura Oncology posts deeper annual loss but lifts net asset backing
Premium
Company Announcements
Racura Oncology posts deeper annual loss but lifts net asset backing
28d ago
Racura Oncology CEO to Spotlight Phase 3 Cancer Programs at TechKnow Invest Conference
Premium
Company Announcements
Racura Oncology CEO to Spotlight Phase 3 Cancer Programs at TechKnow Invest Conference
2M ago
Racura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial
PremiumCompany AnnouncementsRacura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial
3M ago
Race Oncology Options Expire Unexercised, Trimming Potential Dilution
Premium
Company Announcements
Race Oncology Options Expire Unexercised, Trimming Potential Dilution
3M ago
Racura Oncology Begins Dosing in Phase 1 HARNESS-1 Lung Cancer Trial
Premium
Company Announcements
Racura Oncology Begins Dosing in Phase 1 HARNESS-1 Lung Cancer Trial
3M ago
Racura Raises $24.4m as 97% of Piggyback Options Are Exercised
PremiumCompany AnnouncementsRacura Raises $24.4m as 97% of Piggyback Options Are Exercised
4M ago
Racura Oncology Options Lapse, Trimming Potential Equity Dilution
Premium
Company Announcements
Racura Oncology Options Lapse, Trimming Potential Equity Dilution
4M ago
Racura Oncology Raises $31.2m as Specialist Investor Takes Strategic Stake
Premium
Company Announcements
Racura Oncology Raises $31.2m as Specialist Investor Takes Strategic Stake
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100